Literature DB >> 18848533

FDH: an aldehyde dehydrogenase fusion enzyme in folate metabolism.

Sergey A Krupenko1.   

Abstract

FDH (10-formyltetrahydrofolate dehydrogenase, Aldh1L1, EC 1.5.1.6) converts 10-formyltetrahydrofolate (10-formyl-THF) to tetrahydrofolate and CO(2) in a NADP(+)-dependent reaction. It is a tetramer of four identical 902 amino acid residue subunits. The protein subunit is a product of a natural fusion of three unrelated genes and consists of three distinct domains. The N-terminal domain of FDH (residues 1-310) carries the folate binding site and shares sequence homology and structural topology with other enzymes utilizing 10-formyl-THF as a substrate. In vitro it functions as 10-formyl-THF hydrolase, and evidence indicate that this activity is a part of the overall FDH mechanism. The C-terminal domain of FDH (residues 400-902) originated from an aldehyde dehydrogenase-related gene and is capable of oxidation of short-chain aldehydes to corresponding acids. Similar to classes 1 and 2 aldehyde dehydrogenases, this domain exists as a tetramer and defines the oligomeric structure of the full-length enzyme. The two catalytic domains are connected by an intermediate linker (residues 311-399), which is a structural and functional homolog of carrier proteins possessing a 4'-phosphopantetheine prosthetic group. In the FDH mechanism, the intermediate linker domain transfers a formyl, covalently attached to the sulfhydryl group of the phosphopantetheine arm, from the N-terminal domain to the C-terminal domain. The overall FDH mechanism is a coupling of two sequential reactions, a hydrolase and a formyl dehydrogenase, bridged by a substrate transfer step. In this mechanism, one domain provides the folate binding site and a hydrolase catalytic center to remove the formyl group from the folate substrate, another provides a transfer vehicle between catalytic centers and the third one contributes the dehydrogenase machinery further oxidizing formyl to CO(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848533      PMCID: PMC2664990          DOI: 10.1016/j.cbi.2008.09.007

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  109 in total

1.  Structures of apo and complexed Escherichia coli glycinamide ribonucleotide transformylase.

Authors:  R J Almassy; C A Janson; C C Kan; Z Hostomska
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

Review 2.  Enzymes as RNA-binding proteins: a role for (di)nucleotide-binding domains?

Authors:  M W Hentze
Journal:  Trends Biochem Sci       Date:  1994-03       Impact factor: 13.807

Review 3.  The evolutionary history of the first three enzymes in pyrimidine biosynthesis.

Authors:  J N Davidson; K C Chen; R S Jamison; L A Musmanno; C B Kern
Journal:  Bioessays       Date:  1993-03       Impact factor: 4.345

4.  Non-phosphorylating GAPDH of higher plants is a member of the aldehyde dehydrogenase superfamily with no sequence homology to phosphorylating GAPDH.

Authors:  A Habenicht; U Hellman; R Cerff
Journal:  J Mol Biol       Date:  1994-03-18       Impact factor: 5.469

5.  purU, a source of formate for purT-dependent phosphoribosyl-N-formylglycinamide synthesis.

Authors:  P L Nagy; G M McCorkle; H Zalkin
Journal:  J Bacteriol       Date:  1993-11       Impact factor: 3.490

6.  Altered protein expression detected in the F1 offspring of male mice exposed to fission neutrons.

Authors:  C S Giometti; S L Tollaksen; D Grahn
Journal:  Mutat Res       Date:  1994-01       Impact factor: 2.433

7.  Domain structure and function of 10-formyltetrahydrofolate dehydrogenase.

Authors:  D Schirch; E Villar; B Maras; D Barra; V Schirch
Journal:  J Biol Chem       Date:  1994-10-07       Impact factor: 5.157

8.  Aldehyde dehydrogenases: widespread structural and functional diversity within a shared framework.

Authors:  J Hempel; H Nicholas; R Lindahl
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

9.  Enhancement of antineoplastic activity of 5-fluorouracil in mice bearing colon 38 tumor by (6R)5,10-dideazatetrahydrofolic acid.

Authors:  G Pizzorno; S J Davis; D J Hartigan; O Russello
Journal:  Biochem Pharmacol       Date:  1994-06-01       Impact factor: 5.858

10.  OB(oligonucleotide/oligosaccharide binding)-fold: common structural and functional solution for non-homologous sequences.

Authors:  A G Murzin
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  40 in total

1.  Mitochondrial One-Carbon Pathway Supports Cytosolic Folate Integrity in Cancer Cells.

Authors:  Yuxiang Zheng; Ting-Yu Lin; Gina Lee; Marcia N Paddock; Jessica Momb; Zhe Cheng; Qian Li; Dennis L Fei; Benjamin D Stein; Shivan Ramsamooj; Guoan Zhang; John Blenis; Lewis C Cantley
Journal:  Cell       Date:  2018-11-29       Impact factor: 41.582

2.  Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress.

Authors:  L Alexis Hoeferlin; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  Genes Cancer       Date:  2011-09

3.  Molecular comparison of GLT1+ and ALDH1L1+ astrocytes in vivo in astroglial reporter mice.

Authors:  Yongjie Yang; Svetlana Vidensky; Lin Jin; Chunfa Jie; Ileana Lorenzini; Miriam Frankl; Jeffrey D Rothstein
Journal:  Glia       Date:  2011-02       Impact factor: 7.452

4.  Altered folate binding protein expression and folate delivery are associated with congenital hydrocephalus in the hydrocephalic Texas rat.

Authors:  Alicia Requena Jimenez; Naila Naz; Jaleel A Miyan
Journal:  J Cereb Blood Flow Metab       Date:  2018-05-25       Impact factor: 6.200

5.  Transcriptomic, proteomic, and metabolomic landscape of positional memory in the caudal fin of zebrafish.

Authors:  Jeremy S Rabinowitz; Aaron M Robitaille; Yuliang Wang; Catherine A Ray; Ryan Thummel; Haiwei Gu; Danijel Djukovic; Daniel Raftery; Jason D Berndt; Randall T Moon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

6.  The mechanism of discrimination between oxidized and reduced coenzyme in the aldehyde dehydrogenase domain of Aldh1l1.

Authors:  Yaroslav Tsybovsky; Yuryi Malakhau; Kyle C Strickland; Sergey A Krupenko
Journal:  Chem Biol Interact       Date:  2013-01-05       Impact factor: 5.192

7.  Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.

Authors:  Xiao-Qian Chen; Juan-Ru He; Hui-Yun Wang
Journal:  Med Oncol       Date:  2011-10-11       Impact factor: 3.064

8.  Association between ALDH1L1 gene polymorphism and neural tube defects in the Chinese Han population.

Authors:  Lihua Wu; Xiaolin Lu; Jin Guo; Ting Zhang; Fang Wang; Yihua Bao
Journal:  Neurol Sci       Date:  2016-03-18       Impact factor: 3.307

Review 9.  Molecular mechanisms underlying the potentially adverse effects of folate.

Authors:  Kyle C Strickland; Natalia I Krupenko; Sergey A Krupenko
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

10.  Acyl carrier protein-specific 4'-phosphopantetheinyl transferase activates 10-formyltetrahydrofolate dehydrogenase.

Authors:  Kyle C Strickland; L Alexis Hoeferlin; Natalia V Oleinik; Natalia I Krupenko; Sergey A Krupenko
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.